Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to ropivacaine for femoral nerve block in femoral fracture surgery
IRCT20180325039148N5Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of magnesium sulfate and ropivacaine in femoral fracture (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Postoperative pain. Started Oct 2021; status: completed.
02
Drugs
magnesium sulfateropivacaine
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20180325039148N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180325039148N5.